Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery -- a systematic literature review.
Why the study?
Does the choice of specific inotropic drugs improve clinical or physiological outcomes in adult patients after cardiac surgery?
Population
Adult patients requiring temporary inotropic support after cardiac surgery
Comparison
Inotropic drug therapy vs Placebo or alternative inotropic agents
Design
Systematic_review
Authors
Discussion
Loading...
Member takes
Implication
No inotrope can yet be preferred after cardiac surgery; leaves open the need for head-to-head RCTs to guide selection.
Key Points
- To systematically evaluate, present, and classify clinical evidence regarding the selection and efficacy of inotropic drug therapies following adult cardiac surgery.
- Conducted a systematic literature review assessing inotropic agents, including beta-agonists and phosphodiesterase inhibitors (PDIs), in adult cardiac surgery patients.
- Dobutamine and PDIs effectively treat low cardiac output syndrome, with dobutamine having the best-studied profile among beta-agonists but higher rates of tachycardia and tachyarrhythmias.
- PDIs significantly increase the likelihood of successful weaning from cardiopulmonary bypass compared with placebo, improve right heart performance, and lower mean pulmonary artery pressure.
- Evidence remains insufficient to recommend a specific inotropic agent over another based on regional perfusion or overall clinical superiority.
Structured PICO
Does the choice of specific inotropic drugs improve clinical or physiological outcomes in adult patients after cardiac surgery?
P
Population
Adult patients requiring temporary inotropic support after cardiac surgery
I
Intervention
Inotropic drug therapy (including dobutamine, phosphodiesterase inhibitors, and other catecholamines)
C
Comparator
Placebo or alternative inotropic agents
O
Outcome
Efficacy in management of low cardiac output syndrome and successful weaning from cardiopulmonary bypass
There is currently insufficient evidence to recommend one specific inotropic agent over another for adult patients after cardiac surgery, highlighting the need for large clinical trials.
Limitations
- Available evidence is limited in quality and scope
- Existing trials focus on physiological rather than clinical outcomes
Cite This Study
Gillies et al. (2005) studied this question.